Drug Profile
Nicardipine sustained release - Beijing CoSci Med Tech
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Amines; Antihypertensives; Dihydropyridines; Ischaemic heart disorder therapies; Nitrobenzenes; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Hypertension
Most Recent Events
- 27 Jul 2016 Chemical structure information added
- 25 Jul 2016 Investigation in Hypertension in China (PO)